TickerFactsScreenerDevelopers

Theravance Biopharma, Inc. (TBPH) — Total Assets

Annual figures by fiscal year, from SEC filings.

2013: $25.18M2014: $337.77M2015: $300.12M2016: $639.25M2017: $441.40M2018: $560.24M2019: $408.83M2020: $469.06M2021: $374.82M2022: $607.40M2023: $382.00M2024: $354.16M2025: $485.57M$485.57M
2013Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$485.57M+37.1%
2024$354.16M-7.3%
2023$382.00M-37.1%
2022$607.40M+62.1%
2021$374.82M-20.1%
2020$469.06M+14.7%
2019$408.83M-27.0%
2018$560.24M+26.9%
2017$441.40M-31.0%
2016$639.25M+113.0%
2015$300.12M-11.1%
2014$337.77M+1241.6%
2013$25.18M—